"Infusions, Subcutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The administration of liquid medication or nutrients under the skin, usually over minutes or hours.
| Descriptor ID |
D055104
|
| MeSH Number(s) |
E02.319.267.510.795
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Infusions, Subcutaneous".
Below are MeSH descriptors whose meaning is more specific than "Infusions, Subcutaneous".
This graph shows the total number of publications written about "Infusions, Subcutaneous" by people in this website by year, and whether "Infusions, Subcutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 5 | 6 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Infusions, Subcutaneous" by people in Profiles.
-
Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases. Cornea. 2021 Sep 01; 40(9):1204-1206.
-
Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination. Ann Allergy Asthma Immunol. 2021 08; 127(2):257-258.
-
Challenges in delivering rheumatology care during COVID-19 pandemic. Clin Rheumatol. 2020 Sep; 39(9):2817-2821.
-
COVID-19 and neuromuscular disorders. Neurology. 2020 06 02; 94(22):959-969.
-
Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020 06; 8(6):1894-1899.e2.
-
A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5). Diabetes Obes Metab. 2019 04; 21(4):961-967.
-
Apomorphine infusion in advanced Parkinson disease. Nat Rev Neurol. 2018 Dec; 14(12):693-694.
-
A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes. J Diabetes Res. 2018; 2018:2791584.
-
Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial. Immunotherapy. 2018 09; 10(13):1149-1161.
-
Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital. J Diabetes Sci Technol. 2018 07; 12(4):880-889.